CD274 and non-small cell lung carcinoma: In conclusion, this study could demonstrate that several altered serum cytokines in patients with advanced NSCLC could be exploited in order to predict efficacy and toxicity of PD-(L)1 monotherapy or ICT more accurately, but they are not suitable for longitudinal disease monitoring and early detection of tumor escape.